Research library

C

grade

In diabetic mice, abaloparatide increased bone formation without enhancing resorption, suggesting a potential for improving alveolar bone health. However, these results need to be validated in human studies.

Not reported in abstract.

summary

A

grade

This systematic review found no significant difference in pain control between osteoanabolic and antiresorptive therapies for osteoporotic vertebral fractures, highlighting the need for further research.

Not reported in abstract.

summary

A

grade

Teriparatide may improve bone mineral density in patients with chronic kidney disease, but the evidence is limited and further research is needed.

Not reported in abstract.

summary

B

grade

Both abaloparatide and romosozumab significantly improved bone mineral density in postmenopausal women with high-risk osteoporosis over 12 months, with no significant differences between the two treatments.

Significant increases in lumbar spine BMD at 12 months, P<0.001.

summary

D

grade

Anti-osteoporotic drugs like denosumab and abaloparatide show limited evidence for improving muscle outcomes in osteosarcopenia, despite their benefits for bone health.

Not reported in abstract.

summary

D

grade

Denosumab and abaloparatide showed lower cardiovascular risk signals compared to other osteoporosis medications, but further evaluation is needed to confirm these findings.

Romosozumab demonstrated the highest ROR for MI (2.38) and stroke (3.72).

summary

C

grade

The Cxcl12+ lineage is a key source of endosteal osteoblasts and adipocytes in adult bone marrow, highlighting its potential as a target for age-related bone disease therapies.

over 60% of endosteal osteoblasts in skeletally mature adult mice from Cxcl12+ lineage

summary

C

grade

Histone methyltransferase inhibitors may reduce lens opacity in diabetic cataract models, but human studies are needed to confirm clinical relevance.

113 genes upregulated and 60 genes downregulated after BIX-01294 treatment.

summary

D

grade

There is currently no strong evidence to support the use of abaloparatide or similar agents for treating bone stress injuries in athletes. Addressing nutritional and metabolic issues remains essential in managing these injuries.

summary

D

grade

This study categorizes skeletal dysplasias based on defects in the parathyroid hormone signaling cascade, offering insights into their molecular mechanisms and radiological features.

summary

C

grade

PTHrP and PTH1R have distinct roles in bone and digit development, with PTHrP uniquely affecting digit morphology in mice models.

summary

C

grade

BMP-2, TGF-β1, and FGF-2 significantly influence AF cell behavior in vitro, suggesting potential roles in tissue remodeling relevant to AIS development.

Higher DNA content under BMP-2 and TGF-β1 stimulation.

summary

C

grade

Tumor-derived PTHrP may be linked to the suppression of drug-metabolizing enzymes, but further research is needed to clarify its role and clinical implications.

Not reported in abstract.

summary

B

grade

This case highlights the importance of genetic diagnosis in managing rare conditions like iPPSD1, particularly in identifying novel variants that may inform treatment strategies.

Not reported in abstract.

summary

A

grade

Abaloparatide did not show a significant benefit over placebo in healing pelvic fractures within 3 months in this study.

No significant difference in bridging score distribution (p=0.15) between ABL and PBO at 3 months.

summary

A

grade

Palopegteriparatide may help maintain normal levels of 1,25-dihydroxy vitamin D in patients with hypoparathyroidism over a period of 3.5 years.

Not reported in abstract.

summary

B

grade

Low PKLR expression in cholangiocarcinoma is associated with poor survival, indicating its potential as a prognostic biomarker.

PKLR mRNA levels were significantly correlated with tumor size (p=0.024) and metastasis (p=0.014).

summary

D

grade

Hip fractures are common in older adults, with a 1-year mortality rate of 22%, highlighting the need for effective prevention and rehabilitation strategies.

The median 1-year mortality rate after a hip fracture is 22%.

summary

B

grade

Careful monitoring of calcium levels is crucial for hypoparathyroid patients during pregnancy and lactation to prevent hypercalcemia.

summary

C

grade

DMP1-Cre expressing cells are essential for bone mass gain induced by abaloparatide, but not for increased bone remodeling.

PTH/ABL increased bone mass and strength only in fl/fl littermates.

summary

C

grade

Parathyroid hormone accelerates tooth movement in mice by promoting alveolar bone remodeling and metabolic changes in periodontal ligament stem cells.

Not reported in abstract.

summary

C

grade

KDM6A is critical for chondrocyte-to-osteoblast transdifferentiation and fracture healing, but its clinical relevance in humans requires further investigation.

Not reported in abstract.

summary

C

grade

TFF1 suppresses the TCA cycle in TNBC, promoting bone metastasis, but findings are based on mouse models and need human validation.

Deletion of TFF1 reduced metastatic burden and extended survival in mouse models.

summary

D

grade

This review enhances understanding of PTH1R signaling, highlighting potential drug targets but requires further clinical validation.

summary

D

grade

Callus geometry shows promise as a biomarker for fracture healing but requires further clinical validation.

Not reported in abstract.

summary